Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions

Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions

What You Should Know:

Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care.

– Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer.

– This collaborative agreement combines VUNO’s AI R&D capabilities and Mayo Clinic’s AI research, clinical expertise, resources, to develop a broad spectrum of predictive and prognostic biomarkers, for aiding therapeutic decisions that will improve the quality of cancer patient care.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 21, 2024 at 12:56pm